Evelo Biosciences | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,260 results for “Evelo Biosciences”

Biotech Stock Roundup: Aldeyra Faces Setback, Annovis Bio Shows Positive Updates, and More

Medipost Expands US Presence, Advances CARTISTEM Phase III Trial for Knee Osteoarthritis

Seres Therapeutics Appoints Co-CEOs as Company Seeks Partnerships for SER-155 Development

Seres Therapeutics' Microbiome Drug Fails Phase 2 Ulcerative Colitis Trial, Casting Shadow Over Emerging Field

Robust Pipeline of 80+ Therapies Advancing in Psoriasis Treatment Landscape

Microbiome Therapeutics Market Poised to Surge from $288.8M to $4B by 2034, Driven by Defined Consortia and Immuno-Oncology Innovations

FDA Grants Orphan Drug Designation to Pilatus Biosciences' PLT012 for Liver and Bile Duct Cancer

Tyra Biosciences Advances FGFR Inhibitor Pipeline with Multiple Clinical Trials

Caribou Biosciences Price Target Increased by Brookline

Cellectar Biosciences Advances in Cancer Treatment Research

Page 1 of 145